Citadel Advisors’s Guardian Pharmacy Services GRDN Stock Holding History

Citadel Advisors’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.68M	Sell	87,775 -491,346	-85%	-$19M	﹤0.01%	5275
2026 Q1	$21.8M	Buy	+579,121	New	+$18.9M	﹤0.01%	2232
2025 Q4	–	Sell	-77,663	Closed	-$2.04M	–	14435
2025 Q3	$2.04M	Sell	77,663 -241,585	-76%	-$5.76M	﹤0.01%	6029
2025 Q2	$6.8M	Buy	+319,248	New	+$7.2M	﹤0.01%	3596
2024 Q4	–	Sell	-401,131	Closed	-$6.74M	–	15593
2024 Q3	$6.74M	Buy	+401,131	New	+$6.76M	﹤0.01%	3477

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Citadel Advisors's GRDN Position: Q2 2026 in Review

Citadel Advisors reduced its Guardian Pharmacy Services (GRDN) stake by 85% in Q2 2026, selling an estimated $19M and leaving 87,775 shares worth $3.68M. The position accounts for ﹤0.01% of the portfolio, ranked #5275.

Citadel Advisors first reported a position in GRDN in Q3 2024 and has held it in 5 quarters since. The position peaked at $21.8M in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Citadel Advisors held 87,775 shares of Guardian Pharmacy Services worth $3.68M as of Q2 2026.
Citadel Advisors sold 491,346 Guardian Pharmacy Services shares in Q2 2026, an estimated $19M.
Guardian Pharmacy Services made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5275 holding.
Citadel Advisors first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 5 quarters since.
Citadel Advisors's Guardian Pharmacy Services position peaked at $21.8M in Q1 2026.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.